Stocks/APLD

APLD three-lens brief

Evidence-based stock research on APLD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$13.12$17.91$50.73

Performance

1W
+7.8%
1M
-23.0%
3M
-41.5%
6M
—
YTD
—
1Y
—
3Y
—
5Y
—
APLD · Nightly brief
Concern

Price up 7.37% in the last session — a material single-day move. · Trading at 13% of its 52-week range — deep in the lower band.

  • Price up 7.37% in the last session — a material single-day move.
  • Trading at 13% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 26.1pp over 30 days.
  • Currently unprofitable on a trailing basis — no P/E multiple available.

APLD closed at $17.91 (+7.37%) as of 2026-11-12. Market cap: $5.42B. Price is below the 50-day MA and below the 200-day MA. Positives: price up 7.37% in the last session — a material single-day move.; analyst mean target $59.94 — 235% above current (16 analysts).. Concerns: trading at 13% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $341.88M, net income -$237.08M, free cash flow -$4.28B.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on APLD, not one.

A single reasoning model has blind spots it doesn’t know about. We examine APLD across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/APLD"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath APLD brief"></iframe>